Association of ghost Na+/K+-ATPase activity and 2,3-bisphosphoglycerate levels with deferoxamine use in β-thalassemia

β - t halassemia is set of genetic illnesses defined by abnormalities in the synthesis of the beta chains of hemoglobin . A broad spectrum of phenotypes is observed, they are presented inside red blood cells . 2,3-bisphosphoglycerate (2,3-bpg) is a key comp o nent that controls the hemoglobin's oxygen binding. The study examined the effect of the drug deferoxamine on the levels of 2,3-bisphosphoglycerate, Na + /K + ATPase in patients with thalassemia type beta. The study was a case-control study. A total of 130 individuals were involved: a total of 70 patients with β -thalassemia, 60 healthy controls. The initial group was carefully selected based on the patients' clinical symptoms. The 2,3-bisphosphoglycerate level was determined by using the enzyme -linked imm u ne sorbent assay (ELISA ) , while Na + /K + ATPase was measured by ghost . Patients e xhibited elevated 2,3-bisphosphoglyce rate levels in comparison to the control group, accompanied by elevated Na + /K + ATPase levels in patients compar ed to the controls. Elevated levels of 2,3- b isphosphoglycerate dehydrogenase in β- thalassemia patients are due to increased hemolysis, as it is formed within the red blood cell as a result of glycolysis. The level of s odium potassium ATPase, present in the red blood cell membrane, also rises during red blood cell breakdown.